Predicting High-Risk Patients with Lung Adenocarcinoma: The Power of Plasma Cell-Related Genes
We constructed a risk assessment model for LUAD patients based on these genes. This model achieved breakthroughs in predicting the prognosis of LUAD patients with different risk levels and identifying potential immune targets, which were validated in the TCGA-LUAD clinical samples.
Authors
- Xianqiang Zhou (ORCID: https://orcid.org/0000-0003-4736-9123)
- Weibin Tian
- Lei Wang (ORCID: https://orcid.org/0000-0001-8412-1130)
- Shen Yao (ORCID: https://orcid.org/0000-0001-5130-1928)
- Jian Gao (ORCID: https://orcid.org/0000-0002-9404-8771)
- Junyi Xia (ORCID: https://orcid.org/0009-0004-2431-9160)
Institutions
- Peking University (CN)
- Peking University People's Hospital (CN)
- Pudong Medical Center (CN)
Publication Details
- Journal
- Oncology
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1159/000543101
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00